Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
REPLIGEN CORP.
Repligen Corp.
XNAS: RGEN
Momentum Trap
Download real time
161.69
-0.34
(
-0.21
%)
57.04% Gain from 52W Low
741.5K
XNAS Volume
XNAS
15 Jan, 2026 4:30 PM (EST)
Watchlist
Portfolio
Alert
My Notes
Overview
Buy Sell Zone
Financials
Technicals
Price History/Seasonality
Ownership
Politician Trades
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Repligen Corp - RGEN - stock price prediction, stock price target, analyst ratings from 21 analysts
Repligen Corp has a share price target of US$ 190, revenue growth forecast of 15.6%, and profit growth estimate of 287.2% for FY25, based on top 21 analyst calls.
Forecaster Screeners